Back to Search
ANDREW POLIS, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1629862859Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
PMID 19539078·Am J Cardiol·2009
4-observational
Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
PMID 19508464·Diabetes Obes Metab·2009
4-observational
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
PMID 18420099·J Am Coll Cardiol·2008
4-observational
Maternal syphilis and intimate partner violence in Bolivia: a gender-based analysis of implications for partner notification and universal screening.
PMID 17592389·Sex Transm Dis·2007
8-other
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.
PMID 17425547·Int Wound J·2007
4-observational
Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.
PMID 17304660·J Rheumatol·2007
4-observational
Does dermal thermometry predict clinical outcome in diabetic foot infection? Analysis of data from the SIDESTEP* trial.
PMID 17199766·Int Wound J·2006
8-other
Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
PMID 17165637·Mayo Clin Proc·2006
4-observational
Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
PMID 16834834·Curr Med Res Opin·2006
4-observational
Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone.
PMID 16484875·J Clin Rheumatol·2006
4-observational
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.
PMID 16048928·Antimicrob Agents Chemother·2005
3-trial
Report of specific cardiovascular outcomes of the ADVANTAGE trial.
PMID 15968005·Ann Intern Med·2005
8-other
Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
PMID 15940774·J Rheumatol·2005
3-trial
Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials.
PMID 15556830·J Pain·2004
3-trial
Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets.
PMID 15196296·Cephalalgia·2004
3-trial
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
PMID 15086644·J Am Geriatr Soc·2004
3-trial
Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
PMID 14530224·Ann Intern Med·2003
3-trial
Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
PMID 12623832·Ophthalmology·2003
3-trial
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.
PMID 12570120·Eur Respir J·2003
3-trial
Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
PMID 12099542·J Ocul Pharmacol Ther·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 40 SUNSHINE COTTAGE RD
VALHALLA, NY 10595 - Phone
- (914) 594-2440
Quick Facts
- NPI
- 1629862859
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile